Alternative approaches to antiviral treatments: Focusing on glycosylation as a target for antiviral therapy

Biotechnology and Applied Biochemistry

Volumn 56, Issue 3, 2010, Pages 103-109

  Merry, Tony ^a   Astrautsova, Sviatlana ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

AIDS; Antiviral; Glycomimetic; Glycosylation; Hepatitis B; Influenza; Post translational modification

Indexed keywords

COMPUTER VIRUSES; DRUG PRODUCTS; DRUG PRODUCTS PLANTS; ESTERIFICATION; MACHINERY; VIRUSES;

ALTERNATIVE APPROACH; ANTIVIRAL THERAPY; ANTIVIRAL TREATMENTS; CLINICAL TRIAL; GLYCOMIMETIC; HEPATITIS B; HEPATITIS C; PHARMACEUTICAL INDUSTRY; POST-TRANSLATIONAL MODIFICATIONS; PRECLINICAL DEVELOPMENT; SURFACE GLYCOSYLATION; VIRAL DISEASE; VIRAL INFECTIONS; VIRAL PROTEINS;

GLYCOSYLATION;

2G12 ANTIBODY; ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; CYANOVIRIN N; DI N BUTYLDEOXYNOJIRIMYCIN; FLUDASE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INTEGRASE INHIBITOR; LAMIVUDINE; MIGLUSTAT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OSELTAMIVIR; PROTEINASE INHIBITOR; RECOMBINANT ENZYME; SIALIDASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZANAMIVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; DENGUE; DRUG DESIGN; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; FLAVIVIRUS INFECTION; GAUCHER DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LIFE CYCLE; MOLECULAR MECHANICS; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SPECIES DIVERSITY; VIRUS ENTRY; VIRUS MUTATION; VIRUS REPLICATION; ACQUIRED IMMUNODEFICIENCY SYNDROME; GLYCOSYLATION; INFLUENZA, HUMAN;

HEPATITIS C VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIVIRAL AGENTS; GLYCOSYLATION; HEPATITIS C; HUMANS; INFLUENZA, HUMAN; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77954821168     PISSN: 08854513     EISSN: None     Source Type: Journal    
DOI: 10.1042/BA20100010     Document Type: Short Survey

References (38)

1. Balzarini, J. (2007) Nat. Rev. Microbiol. 5, 583-597
2. De Clercq, E. and Neyts, J. (2009) Handb. Exp. Pharmacol, 53-84
3. Burke, J. D. and Fish, E. N. (2009) Curr. Mol. Pharmacol. 2, 32-39
4. Berdis, A. J. (2008) Biochemistry 47, 8253-8260
5. Wensing, A. M. J., van Maarseveen, N. M. and Nijhuis, M. (2010) Antiviral Res. 85, 59-74
6. Olofsson, S. and Hansen, J. E. (1998) Scand. J. Infect. Dis. 30, 435-240
7. Winkler, W. G. (1970) J. Wildl. Dis. 6, 239-242; discussion 247-248
8. Gatherer, D. (2009) J. Clin. Virol. 45, 174-178
9. Xu, R., Ekiert, D. C., Krause, J. C., Hai, R., Crowe, J. E. J. and Wilson, I. A. (2010) Science 328, 357-360
10. Peiris, J. S. M., Tu, W. and Yen, H. (2009) Eur. J. Immunol. 39, 2946-2954
11. Kim, C. U., Chen, X. and Mendel, D. B. (1999) Antivir. Chem. Chemother. 10, 141-154
12. Mochalova, L., Kurova, V., Shtyrya, Y., Korchagina, E., Gambaryan, A., Belyanchikov, I., Korchagina, E. and Bovin, N. (2007) Arch. Virol. 152, 2047-2057
13. Stevens, J., Blixt, O., Paulson, J. C. and Wilson, I. A. (2006) Nat. Rev. Microbiol. 4, 857-864
14. Gambaryan, A., Yamnikova, S., Lvov, D., Tuzikov, A., Chinarev, A., Pazynina, G., Webster, R., Matrosovich, M. and Bovin, N. (2005) Virology 334, 276-283
15. Stevens, J., Blixt, O., Tumpey, T. M., Taubenberger, J. K., Paulson, J. C. and Wilson, I. A. (2006) Science 312, 404-410
16. Wang, B., Dwyer, D., Blyth, C., Soedjono, M., Shi, H., Kesson, A., Ratnamohan, M., McPhie, K., Cunningham, A. L. and Saksena, N. K. (2010) Antiviral Res. 87, 16-21
17. Carbain, B., Martin, S. R., Collins, P. J., Hitchcock, P. B. and Streicher, H. (2009) Org. Biomol. Chem. 7, 2570-2575
18. Hedlund, M., Aschenbrenner, L. M., Jensen, K., Larson, J. L. and Fang, F. (2010) J. Infect. Dis. 201, 1007-1015
19. Karpas, A., Fleet, G. W., Dwek, R. A., Petursson, S., Namgoong, S. K., Ramsden, N. G., Jacob, G. S. and Rademacher, T. W. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 9229-9233
20. Fleet, G. W., Fellows, L. E. and Winchester, B. (1990) Ciba Found. Symp. 154, 112-122; discussion 122-125
21. Fleet, G. W., Karpas, A., Dwek, R. A., Fellows, L. E., Tyms, A. S., Petursson, S., Namgoong, S. K., Ramsden, N. G., Smith, P. W. and Son, J. C. (1988) FEBS Lett. 237, 128-132
22. Lu, X., Mehta, A., Dwek, R., Butters, T. and Block, T. (1995) Virology 213, 660-665
23. Durantel, D., Alotte, C. and Zoulim, F. (2007) Curr. Opin Investig. Drugs 8, 125-129
24. Helenius, A. and Aebi, M. (2004) Annu. Rev. Biochem. 73, 1019-1049
25. Mehta, A., Zitzmann, N., Rudd, P. M., Block, T. M. and Dwek, R. A. (1998) FEBS Lett. 430, 17-22
26. Zitzmann, N., Block, T., Methta, A., Rudd, P., Burton, D., Wilson, I., Platt, F., Butters, T. and Dwek, R. A. (2005) Adv. Exp. Med. Biol. 564, 1-2
27. Chang, J., Wang, L., Ma, D., Qu, X., Guo, H., Xu , X., Mason, P.M., Bourne, M., Moriarty, R., Gu, B. et al. (2009) Antimicrob. Agents Chemother. 53, 1501-1508
28. Abe, Y., Takashita, E., Sugawara, K., Matsuzaki, Y., Muraki, Y. and Hongo, S. (2004) J. Virol. 78, 9605-9611
29. Tomiyama, T., Lake, D., Masuho, Y. and Hersh, E. M. (1991) Biochem. Biophys. Res. Commun. 177, 279-285
30. Vigerust, D. J. and Shepherd, V. L. (2007) Trends Microbiol. 15, 211-218
31. West, A. P. J., Galimidi, R. P., Foglesong, C. P., Gnanapragasam, P. N. P., Huey-Tubman, K. E., Klein, J. S., Suzuki, M. D., Tiangco, N. E., Vielmetter, J. and Bjorkman, P. J. (2009) J. Virol. 83, 98-104
32. Wang, S., Liang, P., Astronomo, R. D., Hsu, T., Hsieh, S., Burton, D. R. and Wong, C-H. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 3690-3695
33. Xiong, S., Fan, J. and Kitazato, K. (2010) Appl. Microbiol. Biotechnol. 86, 805-812
34. Ernst, B. and Magnani, J. L. (2009) Nat. Rev. Drug Discov. 8, 661-677
35. Cytel Halts Clinical Trials of Cylexin; Development Efforts to Focus on Epimmune's Vaccine Programs, Business Wire, 30 March 1999
36. Seeberger, P. H. (2008) Carbohydr. Res. 343, 1889-1896
37. Meutermans, W., Le, G. T. and Becker, B. (2006) ChemMedChem 1, 1164-1194
38. Thomson, R. J., Haselhorst, T., Dyason, J. C. and von Itzstein, M. (2009) Curr. Drug Deliv. 6, 343-346